Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
The reconciliation culminated in Al-Sharaa’s visit to the White House last week, the first by a Syrian president, and the announcement that Syria had become the 90th member of the US-led Global Coalition Against Daesh.